Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.
Identifieur interne : 001607 ( Main/Corpus ); précédent : 001606; suivant : 001608Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.
Auteurs : Anna K. Kiss ; Agnieszka Bazylko ; Agnieszka Filipek ; Sebastian Granica ; Edyta Jaszewska ; Urszula Kiarszys ; Anita Ko Mider ; Jakub PiwowarskiSource :
- Phytomedicine : international journal of phytotherapy and phytopharmacology [ 1618-095X ] ; 2011.
English descriptors
- KwdEn :
- Adult (MeSH), Anti-Inflammatory Agents (pharmacology), Antioxidants (metabolism), Antioxidants (pharmacology), Cell Survival (drug effects), Cells, Cultured (MeSH), Epilobium (chemistry), Fibroblasts (cytology), Fibroblasts (drug effects), Humans (MeSH), Hydrolyzable Tannins (pharmacology), Inhibitory Concentration 50 (MeSH), Mannosides (pharmacology), Neutrophils (drug effects), Neutrophils (enzymology), Neutrophils (metabolism), Plant Extracts (chemistry), Plant Extracts (pharmacology), Plants, Medicinal (chemistry), Poland (MeSH), Quercetin (analogs & derivatives), Quercetin (pharmacology), Reactive Oxygen Species (metabolism), Skin (drug effects).
- MESH :
- chemical , analogs & derivatives : Quercetin.
- chemical , chemistry : Plant Extracts.
- chemical , metabolism : Antioxidants, Reactive Oxygen Species.
- chemical , pharmacology : Anti-Inflammatory Agents, Antioxidants, Hydrolyzable Tannins, Mannosides, Plant Extracts, Quercetin.
- geographic : Poland.
- chemistry : Epilobium, Plants, Medicinal.
- cytology : Fibroblasts.
- drug effects : Cell Survival, Fibroblasts, Neutrophils, Skin.
- enzymology : Neutrophils.
- metabolism : Neutrophils.
- Adult, Cells, Cultured, Humans, Inhibitory Concentration 50.
Abstract
Willow herb tea or preparation are available and relatively popular in the European market, and claimed to be effective inter alia because of their anti-inflammatory activity. The present study is therefore aimed at comparing the anti-inflammatory and antioxidant activity of extracts of the three most popular Epilobium species (E. angustifolium, E. hirsutum and E. parviflorum) and at juxtaposing this activity against the dominating compounds from the following extracts: oenothein B (OeB), quercetin-3-O-glucuronide and myricetin-3-O-rhamnoside. The phytochemical analysis of the extracts has shown that OeB quantities vary between 20% and 35%, while flavonoids content does not exceed 2%. All extracts have inhibited the activity of hyaluronidase and lipoxygenase with IC₅₀ around 5 μg/ml and 25 μg/ml. The inhibition of hyaluronidase is related with the presence of OeB, a strong inhibitor of this enzyme (IC₅₀) 1.1 μM). Additionally, the extracts inhibited myeloperoxidase (MPO) release from stimulated neutrophils. OeB inhibited MPO release similarly to the anti-inflammatory drug indomethacin with IC₅₀ 7.7 μM and 15.4 μM, respectively. Tested extracts significantly reduced the production of reactive oxygen species (ROS) from f-MLP and PMA induced neutrophils with IC₅₀ 5 μg/ml and 25 μg/ml, respectively. The flavonoids content seems to exert little influence on extracts' activity, contrary to OeB, whose high concentration explains the activity of extract obtained from Epilobium. Tested currently marketed Epilobium preparations are often wrongly assigned, but we should stress that the level of OeB in all tested herbs was high and always exceeded 2% in raw material.
DOI: 10.1016/j.phymed.2010.10.016
PubMed: 21112753
Links to Exploration step
pubmed:21112753Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.</title><author><name sortKey="Kiss, Anna K" sort="Kiss, Anna K" uniqKey="Kiss A" first="Anna K" last="Kiss">Anna K. Kiss</name><affiliation><nlm:affiliation>Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland. akiss@wum.edu.pl</nlm:affiliation></affiliation></author><author><name sortKey="Bazylko, Agnieszka" sort="Bazylko, Agnieszka" uniqKey="Bazylko A" first="Agnieszka" last="Bazylko">Agnieszka Bazylko</name></author><author><name sortKey="Filipek, Agnieszka" sort="Filipek, Agnieszka" uniqKey="Filipek A" first="Agnieszka" last="Filipek">Agnieszka Filipek</name></author><author><name sortKey="Granica, Sebastian" sort="Granica, Sebastian" uniqKey="Granica S" first="Sebastian" last="Granica">Sebastian Granica</name></author><author><name sortKey="Jaszewska, Edyta" sort="Jaszewska, Edyta" uniqKey="Jaszewska E" first="Edyta" last="Jaszewska">Edyta Jaszewska</name></author><author><name sortKey="Kiarszys, Urszula" sort="Kiarszys, Urszula" uniqKey="Kiarszys U" first="Urszula" last="Kiarszys">Urszula Kiarszys</name></author><author><name sortKey="Ko Mider, Anita" sort="Ko Mider, Anita" uniqKey="Ko Mider A" first="Anita" last="Ko Mider">Anita Ko Mider</name></author><author><name sortKey="Piwowarski, Jakub" sort="Piwowarski, Jakub" uniqKey="Piwowarski J" first="Jakub" last="Piwowarski">Jakub Piwowarski</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21112753</idno><idno type="pmid">21112753</idno><idno type="doi">10.1016/j.phymed.2010.10.016</idno><idno type="wicri:Area/Main/Corpus">001607</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001607</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.</title><author><name sortKey="Kiss, Anna K" sort="Kiss, Anna K" uniqKey="Kiss A" first="Anna K" last="Kiss">Anna K. Kiss</name><affiliation><nlm:affiliation>Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland. akiss@wum.edu.pl</nlm:affiliation></affiliation></author><author><name sortKey="Bazylko, Agnieszka" sort="Bazylko, Agnieszka" uniqKey="Bazylko A" first="Agnieszka" last="Bazylko">Agnieszka Bazylko</name></author><author><name sortKey="Filipek, Agnieszka" sort="Filipek, Agnieszka" uniqKey="Filipek A" first="Agnieszka" last="Filipek">Agnieszka Filipek</name></author><author><name sortKey="Granica, Sebastian" sort="Granica, Sebastian" uniqKey="Granica S" first="Sebastian" last="Granica">Sebastian Granica</name></author><author><name sortKey="Jaszewska, Edyta" sort="Jaszewska, Edyta" uniqKey="Jaszewska E" first="Edyta" last="Jaszewska">Edyta Jaszewska</name></author><author><name sortKey="Kiarszys, Urszula" sort="Kiarszys, Urszula" uniqKey="Kiarszys U" first="Urszula" last="Kiarszys">Urszula Kiarszys</name></author><author><name sortKey="Ko Mider, Anita" sort="Ko Mider, Anita" uniqKey="Ko Mider A" first="Anita" last="Ko Mider">Anita Ko Mider</name></author><author><name sortKey="Piwowarski, Jakub" sort="Piwowarski, Jakub" uniqKey="Piwowarski J" first="Jakub" last="Piwowarski">Jakub Piwowarski</name></author></analytic><series><title level="j">Phytomedicine : international journal of phytotherapy and phytopharmacology</title><idno type="eISSN">1618-095X</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Anti-Inflammatory Agents (pharmacology)</term><term>Antioxidants (metabolism)</term><term>Antioxidants (pharmacology)</term><term>Cell Survival (drug effects)</term><term>Cells, Cultured (MeSH)</term><term>Epilobium (chemistry)</term><term>Fibroblasts (cytology)</term><term>Fibroblasts (drug effects)</term><term>Humans (MeSH)</term><term>Hydrolyzable Tannins (pharmacology)</term><term>Inhibitory Concentration 50 (MeSH)</term><term>Mannosides (pharmacology)</term><term>Neutrophils (drug effects)</term><term>Neutrophils (enzymology)</term><term>Neutrophils (metabolism)</term><term>Plant Extracts (chemistry)</term><term>Plant Extracts (pharmacology)</term><term>Plants, Medicinal (chemistry)</term><term>Poland (MeSH)</term><term>Quercetin (analogs & derivatives)</term><term>Quercetin (pharmacology)</term><term>Reactive Oxygen Species (metabolism)</term><term>Skin (drug effects)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Quercetin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Plant Extracts</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antioxidants</term><term>Reactive Oxygen Species</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Antioxidants</term><term>Hydrolyzable Tannins</term><term>Mannosides</term><term>Plant Extracts</term><term>Quercetin</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Poland</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Epilobium</term><term>Plants, Medicinal</term></keywords><keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Fibroblasts</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Survival</term><term>Fibroblasts</term><term>Neutrophils</term><term>Skin</term></keywords><keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Neutrophils</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Neutrophils</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cells, Cultured</term><term>Humans</term><term>Inhibitory Concentration 50</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Willow herb tea or preparation are available and relatively popular in the European market, and claimed to be effective inter alia because of their anti-inflammatory activity. The present study is therefore aimed at comparing the anti-inflammatory and antioxidant activity of extracts of the three most popular Epilobium species (E. angustifolium, E. hirsutum and E. parviflorum) and at juxtaposing this activity against the dominating compounds from the following extracts: oenothein B (OeB), quercetin-3-O-glucuronide and myricetin-3-O-rhamnoside. The phytochemical analysis of the extracts has shown that OeB quantities vary between 20% and 35%, while flavonoids content does not exceed 2%. All extracts have inhibited the activity of hyaluronidase and lipoxygenase with IC₅₀ around 5 μg/ml and 25 μg/ml. The inhibition of hyaluronidase is related with the presence of OeB, a strong inhibitor of this enzyme (IC₅₀) 1.1 μM). Additionally, the extracts inhibited myeloperoxidase (MPO) release from stimulated neutrophils. OeB inhibited MPO release similarly to the anti-inflammatory drug indomethacin with IC₅₀ 7.7 μM and 15.4 μM, respectively. Tested extracts significantly reduced the production of reactive oxygen species (ROS) from f-MLP and PMA induced neutrophils with IC₅₀ 5 μg/ml and 25 μg/ml, respectively. The flavonoids content seems to exert little influence on extracts' activity, contrary to OeB, whose high concentration explains the activity of extract obtained from Epilobium. Tested currently marketed Epilobium preparations are often wrongly assigned, but we should stress that the level of OeB in all tested herbs was high and always exceeded 2% in raw material.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21112753</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1618-095X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2011</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Phytomedicine : international journal of phytotherapy and phytopharmacology</Title><ISOAbbreviation>Phytomedicine</ISOAbbreviation></Journal><ArticleTitle>Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.</ArticleTitle><Pagination><MedlinePgn>557-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phymed.2010.10.016</ELocationID><Abstract><AbstractText>Willow herb tea or preparation are available and relatively popular in the European market, and claimed to be effective inter alia because of their anti-inflammatory activity. The present study is therefore aimed at comparing the anti-inflammatory and antioxidant activity of extracts of the three most popular Epilobium species (E. angustifolium, E. hirsutum and E. parviflorum) and at juxtaposing this activity against the dominating compounds from the following extracts: oenothein B (OeB), quercetin-3-O-glucuronide and myricetin-3-O-rhamnoside. The phytochemical analysis of the extracts has shown that OeB quantities vary between 20% and 35%, while flavonoids content does not exceed 2%. All extracts have inhibited the activity of hyaluronidase and lipoxygenase with IC₅₀ around 5 μg/ml and 25 μg/ml. The inhibition of hyaluronidase is related with the presence of OeB, a strong inhibitor of this enzyme (IC₅₀) 1.1 μM). Additionally, the extracts inhibited myeloperoxidase (MPO) release from stimulated neutrophils. OeB inhibited MPO release similarly to the anti-inflammatory drug indomethacin with IC₅₀ 7.7 μM and 15.4 μM, respectively. Tested extracts significantly reduced the production of reactive oxygen species (ROS) from f-MLP and PMA induced neutrophils with IC₅₀ 5 μg/ml and 25 μg/ml, respectively. The flavonoids content seems to exert little influence on extracts' activity, contrary to OeB, whose high concentration explains the activity of extract obtained from Epilobium. Tested currently marketed Epilobium preparations are often wrongly assigned, but we should stress that the level of OeB in all tested herbs was high and always exceeded 2% in raw material.</AbstractText><CopyrightInformation>Copyright © 2010 Elsevier GmbH. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Anna K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland. akiss@wum.edu.pl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazylko</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Filipek</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Granica</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Jaszewska</LastName><ForeName>Edyta</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Kiarszys</LastName><ForeName>Urszula</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Kośmider</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Piwowarski</LastName><ForeName>Jakub</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Phytomedicine</MedlineTA><NlmUniqueID>9438794</NlmUniqueID><ISSNLinking>0944-7113</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047348">Hydrolyzable Tannins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008362">Mannosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C529905">myricetin-3-O-rhamnoside</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C443401">quercetin 3-O-glucuronide</NameOfSubstance></Chemical><Chemical><RegistryNumber>104987-36-2</RegistryNumber><NameOfSubstance UI="C080077">oenothein B</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D031666" MajorTopicYN="N">Epilobium</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047348" MajorTopicYN="N">Hydrolyzable Tannins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008362" MajorTopicYN="N">Mannosides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010946" MajorTopicYN="N">Plants, Medicinal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>09</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21112753</ArticleId><ArticleId IdType="pii">S0944-7113(10)00333-8</ArticleId><ArticleId IdType="doi">10.1016/j.phymed.2010.10.016</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001607 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001607 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= WillowV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:21112753
|texte= Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:21112753" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a WillowV1
| This area was generated with Dilib version V0.6.37. |  |